Letermovir Prophylaxis in Children With EBV-Positive T/NK-Cell Lymphoproliferative Disease and Refractory/Relapsed EBV-Associated Hemophagocytic Lymphohistiocytosis

Clinical trial NCT07488728 · RECRUITING

Trial details

NCT number: NCT07488728
Sponsor: Beijing Children's Hospital
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

EBV-associated T/NK-cell Lymphoproliferative Diseases Refractory/Relapsed EBV-related Hemophagocytic Lymphohistiocytosis Letermovir

Start date: 2025-10-01
Primary completion: 2026-12-31
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.